Anti-STXBP1/MUNC18-1 Antibody, clone 2K7 ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry. This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 2K7 is a ZooMAb® rabbit recombinant monoclonal antibody that specifically detects Syntaxin-binding protein 1 (STCBP1). It targets an epitope within 21 amino acids from the C-terminal region.
• Immunogen: KLH-conjugated linear peptide corresponding to 21 amino acids from the C-terminal region of human Syntaxin-binding protein 1 (STCBP1).
• Application: Quality Control TestingEvaluated by Western Blotting in NIH3T3 cell lysate.Western Blotting Analysis: A 1:1,000 dilution of this antibody detected STXBP1/MUNC18-1 NIH3T3 cell lysate.Tested ApplicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected STXBP1/MUNC18-1 in lysates from HeLa and PC12 cells and Human brain tissue..Affinity Binding Assay:: A representative lot of this antibody bound STXBP1/MUNC-18-1 peptide with a KD of 9.5 x 10-7 in an affinity binding assay.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected STXBP1/MUNC18-1 in Human cerebral cortex tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected STXBP1/MUNC18-1 in HeLa cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
• Target description: Syntaxin-binding protein 1 (UniProt: P61764; also known as MUNC18-1, N-Sec1, Protein unc-18 homolog 1, Unc18-1, Protein unc-18 homolog A, Unc-18A, p67) is encoded by the STXBP1 (also known as UNC18A) gene (Gene ID: 6812) in human. STXBP1 is an essential component of the presynaptic neurotransmitter release machinery and is detected in the brain and spinal cord and is enriched in axons. It binds syntaxin, a component of the synaptic vesicle fusion machinery probably in a 1:1 ratio. It is reported to interact with syntaxins 1, 2, and , but not syntaxin 4. It is involved in presynaptic dense core vesicle exocytosis and synaptic vesicle priming. It participates in the regulation of synaptic vesicle docking and fusion through interaction with GTP-binding proteins. It is involved in the release of neurotransmitters through interacting with SNARE complex component STX1A and mediates the assembly of the SNARE complex at synaptic membranes. STXBP1 is one of the most frequently mutated genes in sporadic intellectual disabilities and developmental disorders. Mutations in this gene are known to cause developmental and epileptic encephalopathy 4 (DEE4), a severe form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonal. (Ref.: Chen, W., et al. (2020). eLife 9; e48705).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.
• Reconstitution: 30 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.